The Pharma Data

FEBRUARY 21, 2022

At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business, which is aimed at delivering long-term, sustainable business growth by bringing forward new options for patients.

Small Molecule 52

Small Molecule Clinical Trials Clinical Development Production 52

Drug Discovery World

JULY 11, 2022

The global cell and gene therapy (CGT) market reached a value of ~$4 billion in 2020 and is expected to grow to ~$34 billion by 2030 1. There are over 7,000 genetic diseases that could potentially be cured using gene therapy 10. Methods& clinical development, 21,524–529. Conclusion. 6: Drago, D., Foss-Campbell, B.,Wonnacott,

Therapies 130

Therapies Clinical Trials Production Trials 130

The Pharma Data

AUGUST 5, 2021

Food and Drug Administration for the treatment of adult patients with chronic kidney disease and type 2 diabetes. The platform already has potentially ground-breaking medical innovations in clinical development, such as a therapy for the treatment of Parkinson’s. The latter product was approved in July by the U.S.

Production 52

Production Pharmaceuticals Science Therapies 52

Drug Discovery World

JUNE 26, 2023

Now, there are many mRNA-based therapeutics in clinical development and mRNA cancer vaccines have been promised by 2030. A partnership between the UK government and BioNTech aims to accelerate clinical trials of personalised immunotherapies for cancer and infectious disease vaccines.

Vaccine 130

Vaccine Virus Clinical Trials Trials 130

Drug Discovery World

APRIL 10, 2024

Determining the best starting doses and titration patterns is often a goal of early phase clinical development. Other design considerations for success While patient-centric trial design was the second-most employed design component for respondents’ obesity-related clinical studies, the first was multi-indication studies (50%).

Clinical Trials 130

Clinical Trials Trials Therapies Treatment 130

Drug Discovery World

FEBRUARY 15, 2023

Cancer is a complex heterogenous multistep disease characterised by uncontrolled cell proliferation combined with a dysregulated immune response. Half of people diagnosed with cancer in England and Wales survive their disease for 10 years or more (2010-11) 1. In vitro models All the above approaches involve the use of animal models.

Research 130

Research Therapies Immune Response Clinical Trials 130

Drug Discovery World

MAY 30, 2023

These targeted cytokines are selectively removed with the intention of neutralising the cancer’s ability to block a patient’s natural immune defence mechanisms, which are significantly compromised in late-stage, metastatic disease. This potentially re-energises the immune system to fight cancers.”

Research 130

Research Targeted Protein Degradation Drugs RNA 130

PerkinElmer

JANUARY 25, 2023

Confronting and containing the spread of other infectious diseases like tuberculosis, influenza A and B as well as respiratory syncytial virus (RSV) also remained top global health priorities, as was testing to prevent the transmission of sexually transmitted infections, tickborne diseases and more.

Science 52

Science Laboratories Immune Response Disease 52

The Pharma Data

FEBRUARY 24, 2022

– Heart failure represents a significant, growing disease burden in the U.S., with more than 8 million cases expected by 2030. vice president, Clinical Development & Medical Affairs, Cardio-Metabolism & Respiratory Medicine, Boehringer Ingelheim Pharmaceuticals, Inc. Source link: [link].

FDA Approval 52

FDA Approval FDA Hospitals Trials 52

The Pharma Data

NOVEMBER 5, 2020

This quarter we had robust top- and bottom-line growth driven by EYLEA in retinal diseases and Dupixent in atopic dermatitis and asthma. Key Pipeline Progress Regeneron has more than 20 product candidates in clinical development, including five marketed products for which it is investigating additional indications.

Production 52

Production FDA FDA Approval Trials 52

Drug Discovery World

NOVEMBER 18, 2022

A study by the Centers for Disease Control and Prevention (CDC) supports this 2 , stating that during the pandemic, the threat of antimicrobial-resistant infections got worse with a 15% reported increase of both hospital-onset infections and deaths in the first year of Covid-19. . antimicrobials has now become beyond human capacity.

Pharmaceutical Companies 130

Pharmaceutical Companies Government Pharmaceuticals Hospitals 130

Codon

MARCH 24, 2024

market with Wegovy will, by 2030, require about one million liters of production capacity. The real cost is clinical development. In 2012, an Israeli company called Protalix gained approval for their plant-based enzyme product for Gaucher’s disease. The total global bioprocessing capacity was estimated at 17.4

Engineering 87

Engineering Vaccine Production RNA 87